Drugs / Bacille Calmette Guérin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03536117 Comparator | Feb 2019 → May 2022 | tuberculosis | Biofabri, S.L | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacille Calmette Guérin | “Safer and more effective tuberculosis (TB) vaccines than Bacille Calmette Guérin (BCG) are needed.” PMID 40101388 ↗ Mar 2025 |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03536117 ↗ |
| Modality | Vaccine | “BCG is the only licensed vaccine today against tuberculosis (TB)” NCT03536117 ↗ |